Navigation Links
Blood-compatible nanoscale materials possible using heparin

Researchers from Rensselaer Polytechnic Institute have engineered nanoscale materials that are blood compatible using heparin, an anticoagulant. The heparin biomaterials have potential for use as medical devices and in medical treatments such as kidney dialysis.

The researchers prepared several materials with heparin composites or coatings, including carbon nanotubes, nanofibers, and membranes with nanosized pores, and then demonstrated the materials' high compatibility with blood. Heparin is a common therapeutic used to maintain blood flow or prevent clotting during medical procedures and treatments.

The researchers demonstrated the composite heparin membrane with nanopores could work as an artificial kidney, or dialyzer, by filtering the blood and maintaining its flow. The presence of this blood-compatible dialyzer could potentially eliminate the need for systemic administration of heparin to the patient during kidney dialysis, the researchers say.

The heparin-coated membranes are described in a paper titled "Ionic Liquid-Derived Blood Compatible Membranes for Kidney Dialysis," published online Apr. 24 in advance of print in the Journal of Biomedical Materials Research.

"These heparin composite membranes and fibers and coated carbon nanotubes are an enabling technology," says Saravanababu Murugesan, a recent doctoral graduate in chemical and biological engineering at Rensselaer and lead author of the paper. "Our results show these novel materials have great promise in the development of improved medical devices that are blood compatible."

The research team is led by Robert Linhardt, the Ann and John H. Broadbent Jr. '59 Senior Constellation Professor of Biocatalysis and Metabolic Engineering at Rensselaer, and includes collaboration with Pulickel Ajayan, the Henry Burlage Professor of Materials Science and Engineering, and Omkaram "Om" Nalamasu, professor of materials science and engineering, at Rensselaer. Additional co-a
'"/>

Source:Rensselaer Polytechnic Institute


Page: 1 2

Related biology news :

1. Marine sponge yields nanoscale secrets
2. Rice scientists make first nanoscale pH meter
3. Embryonic stem cells do better on bumpy nanoscale mattress
4. Spelling out cancer on the nanoscale
5. Researchers to develop active nanoscale surfaces for biological separations
6. Fantastic Voyage: A new nanoscale view of the biological world
7. Bones at the nanoscale
8. Penn researcher shows that DNA gets kinky easily at the nanoscale
9. Purdue proves concept of using nano-materials for drug discovery
10. UCLA scientists store materials in cells natural vaults
11. Nanotextured implant materials: blending in, not fighting back

Post Your Comments:
(Date:11/23/2009)...160 participants gathered this week for the sevent...E conference. This year,s topic, "Synthetic Biolog...dical researchers to explore the engineering, scie... field of synthetic biology. , Bonnie L. Bassler...ersity and this year,s conference chair, challenge...
(Date:11/23/2009)...e vaccine available for the H1N1 virus has been se...us. The vaccination marks the first time vaccine h...ndemic flu., Iowa State University,s Hank Harris...ne this summer and has been shipping preventive do...s for several weeks., The latest vaccines were s...
(Date:11/23/2009)...study by University of Alabama at Birmingham (UAB)...co-existing medical conditions (co-morbidity) do n...frican-Americans compared to Caucasians who also h...v. 23 in Cancer , a journal of the American Cance... BMI and co-morbidity are independent predictors o...
Breaking Biology News(10 mins):Synthetic biology offers new opportunities for interdisciplinary collaboration 2Iowa State researcher produces, ships only H1N1 vaccine available for swine 2Racial disparity in colon cancer survival not easily explained, UAB researchers say 2Cadence Pharmaceuticals Announces Priority Review and Acceptance of NDA Submission for Acetavance 28TM 29 for Treatment of Acute Pain and Fever 51749 1Cadence Pharmaceuticals Announces Priority Review and Acceptance of NDA Submission for Acetavance 28TM 29 for Treatment of Acute Pain and Fever 51749 2Cadence Pharmaceuticals Announces Priority Review and Acceptance of NDA Submission for Acetavance 28TM 29 for Treatment of Acute Pain and Fever 51749 3Cadence Pharmaceuticals Announces Priority Review and Acceptance of NDA Submission for Acetavance 28TM 29 for Treatment of Acute Pain and Fever 51749 4Physician Hospitals 28PHA 29 Responds to TIME Magazine Article 3A Filled With Incorrect Assumption and Innuendo 51747 1Physician Hospitals 28PHA 29 Responds to TIME Magazine Article 3A Filled With Incorrect Assumption and Innuendo 51747 2Physician Hospitals 28PHA 29 Responds to TIME Magazine Article 3A Filled With Incorrect Assumption and Innuendo 51747 3Physician Hospitals 28PHA 29 Responds to TIME Magazine Article 3A Filled With Incorrect Assumption and Innuendo 51747 4China Biotics Inc Reports Fourth Quarter and Full Year Fiscal 2009 Financial Results 13036 1China Biotics Inc Reports Fourth Quarter and Full Year Fiscal 2009 Financial Results 13036 2China Biotics Inc Reports Fourth Quarter and Full Year Fiscal 2009 Financial Results 13036 3China Biotics Inc Reports Fourth Quarter and Full Year Fiscal 2009 Financial Results 13036 4China Biotics Inc Reports Fourth Quarter and Full Year Fiscal 2009 Financial Results 13036 5China Biotics Inc Reports Fourth Quarter and Full Year Fiscal 2009 Financial Results 13036 6China Biotics Inc Reports Fourth Quarter and Full Year Fiscal 2009 Financial Results 13036 7China Biotics Inc Reports Fourth Quarter and Full Year Fiscal 2009 Financial Results 13036 8China Biotics Inc Reports Fourth Quarter and Full Year Fiscal 2009 Financial Results 13036 9China Biotics Inc Reports Fourth Quarter and Full Year Fiscal 2009 Financial Results 13036 10China Biotics Inc Reports Fourth Quarter and Full Year Fiscal 2009 Financial Results 13036 11China Biotics Inc Reports Fourth Quarter and Full Year Fiscal 2009 Financial Results 13036 12China Biotics Inc Reports Fourth Quarter and Full Year Fiscal 2009 Financial Results 13036 13
...p elucidate mechanisms of wake-sleep transitions a...sity of Pennsylvania School of Medicine have demon...called astrocytes are directly involved in regulat...ng of the study is that astrocytes modulate the le...h is thought to be important in controlling wake-t...
...scientists at UCSF sheds light on how the odor det...eir social behavior. , "Understanding how mice pr...tes the sense of smell--should provide insight int... use to transform sensory information into behavio...SF assistant professor of anatomy. , "There are s...
...ldiers guarding a castle gate, multiple genetic de...owdery mildew disease, according to a new study. P...ts that attacks more than 9,000 species, including...tural plants such as roses and cucumbers. The rese...ein of the Carnegie Institution,s Department of Pl...
Other Biology News:Penn study finds direct role for glial cells in brain cross-talk 2New study examines how sense of smell affects mating and aggression in mice 2Genetic defenders protect crops from fungal disease 2Genetic defenders protect crops from fungal disease 3
(Date:11/24/2009)...24/PRNewswire-FirstCall/-HamiltonThorneLtd.(TSX-V:...advancedlasersystemsandinstrumentsforthestemcellre...tionalandfinancialresultsforthethirdquarterendedSe...1.46millioncomparedwith$1.43millioninQ32008,-Gross...nQ3,2008,-Netlossreducedto$148,000comparedto$283,0...
(Date:11/24/2009)...--HealthRoboticstodayannounced,thatithasformedanew....ThisrecentlyformedToronto-basedcompanywilloperate...t,install,andsupport,HealthRobotics,i.v.RoomoftheF...offeringsi.v.STATION(TM),i.v.SOFT(TM),andOMM(TM).,...nan"asneeded,basis"toitsstrategicpartnershipswithM...
(Date:11/23/2009)...vocative new study, a University of Utah scientist...major cause of global warming cannot be stabilize...builds the equivalent of one new nuclear power pla...ll be any substantial near-term departure from rec...sion rates," says the new paper by Tim Garrett, an...
(Date:11/23/2009)...ire-FirstCall/--PDLBioPharma,Inc.(PDL)(Nasdaq: PDL...7,2009astheex-dividenddateforits$200millionspecial...ontransactioncompletedonNovember2,2009.Thedividend...rdontherecorddate,December1,2009.NASDAQhassettheap...eofcommonstockforpurposesoftheex-dividenddateonNov...
Breaking Biology Technology:Hamilton Thorne announces third quarter results 2Hamilton Thorne announces third quarter results 3Hamilton Thorne announces third quarter results 4Hamilton Thorne announces third quarter results 5Hamilton Thorne announces third quarter results 6Hamilton Thorne announces third quarter results 7Health Robotics Continues its Global Expansion With December 09 ASHP's Launch of Joint Venture in Canada 2Is global warming unstoppable? 2Is global warming unstoppable? 3Is global warming unstoppable? 4PDL BioPharma Announces Ex-Dividend Date of November 27 for Special Dividend 2
... , , , , Multiporator / Electr... , , , Transformation... 01/2002 , , , , , ,... Microorganism , Pseudomonas aer...ype , Bacteria, gram negative, ...
... , , , , Multiporator / Electr... , , , Transformatio... 01/2002 , , , , , ,... Microorganism , Nocardia cora...e , Bacteria, gram positive, ,...
... , , , , Multiporator / Electr... , , , Transformatio... 03/2002 , , , , , ,... Microorganism , Mycobacterium... Cell type , Bacteria, gram positive,...
Other Biology Technology:Pseudomonas aeruginosa 2Nocardia corallina 2Mycobacterium smegmatis 2
Acridine orange, hemizinc salt from Research Organics, Inc.
Acridine orange 10-nonyl bromide from AnaSpec
Anti-rat Ig HRP detection kit from BD Biosciences Pharmingen
Wash Solution from CHEMICON
Biology Products: